Norepinephrine Bitartrate Chloride recalls
The FDA has published 2 recalls involving Norepinephrine Bitartrate Chloride since 2024. The latest was reported on 30 Oct 2024. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2024
Last 12 months0reported
Class I00% of total
Ongoing0latest 30 Oct 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why norepinephrine bitartrate chloride is recalled
Companies
By year
All norepinephrine bitartrate chloride recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | NORepinephrine Bitartrate 0.9% Sodium Chloride Injection recalled | Fresenius Kabi Compounding | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | NORepinephrine Bitartrate 0.9% Sodium Chloride Injection recalled | Fresenius Kabi Compounding | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Norepinephrine Bitartrate Chloride?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.